-+ 0.00%
-+ 0.00%
-+ 0.00%

INHIBIKASE THERAPEUTICS ANNOUNCES ENROLLMENT OF FIRST PATIENT IN IMPROVE-PAH GLOBAL PHASE 3 STUDY OF IKT-001 IN THE TREATMENT OF PULMONARY ARTERIAL HYPERTENSION

Reuters·04/07/2026 12:00:02

Please log in to view news